PMID- 26939721
OWN - NLM
STAT- MEDLINE
DCOM- 20170410
LR  - 20221207
IS  - 1365-2710 (Electronic)
IS  - 0269-4727 (Print)
IS  - 0269-4727 (Linking)
VI  - 41
IP  - 3
DP  - 2016 Jun
TI  - Medication adherence may be more important than other behaviours for optimizing 
      glycaemic control among low-income adults.
PG  - 256-9
LID - 10.1111/jcpt.12360 [doi]
AB  - WHAT IS KNOWN: Patients with type 2 diabetes mellitus (T2DM) are required to 
      perform multiple self-care behaviours to achieve and maintain optimal glycaemic 
      control (HbA1c), which prevents complications and premature mortality. Patients 
      with T2DM and low socioeconomic status (SES) are more likely to have suboptimal 
      HbA1c, often due to being less adherent to recommended self-care activities than 
      their higher-SES counterparts. OBJECTIVE: Although studies support performing 
      certain diabetes self-care behaviours for optimizing glycaemic control, there is 
      limited research on the relative importance of each behaviour for this purpose. 
      Identifying what behaviours are most important for HbA1c among low-SES patients 
      with T2DM would be particularly useful for informing policy and intervention 
      efforts for this high-risk group. METHODS: In a cross-sectional study of 314 
      adults with T2DM and low SES, we used the Summary of Diabetes Self-Care 
      Activities to assess self-care behaviours and multivariate models to test which 
      behaviours were associated with lower HbA1c. RESULTS AND DISCUSSION: Only 
      medication adherence was significantly associated with lower HbA1c after 
      adjusting for the other self-care behaviours (beta = -0.14, P = 0.028) and further 
      adjusting for demographic and diabetes characteristics (beta = -0.16, P = 0.024). 
      WHAT IS NEW: Medication adherence may be the most important self-care behaviour 
      for glycaemic control among adults with T2DM and low SES. CONCLUSION: Focused 
      efforts to improve medication adherence among low-SES patient populations may 
      improve glycaemic control.
CI  - (c) 2016 John Wiley & Sons Ltd.
FAU - Osborn, C Y
AU  - Osborn CY
AD  - Vanderbilt University Medical Center, Nashville, TN, USA.
FAU - Mayberry, L S
AU  - Mayberry LS
AUID- ORCID: 0000-0002-0654-4151
AD  - Vanderbilt University Medical Center, Nashville, TN, USA.
FAU - Kim, J M
AU  - Kim JM
AD  - Texas A&M Health Science Center, Bryan, TX, USA.
LA  - eng
GR  - T35 DK007383/DK/NIDDK NIH HHS/United States
GR  - UL1 TR000445/TR/NCATS NIH HHS/United States
GR  - K01 DK106306/DK/NIDDK NIH HHS/United States
GR  - F32 DK097880/DK/NIDDK NIH HHS/United States
GR  - R01 DK100694/DK/NIDDK NIH HHS/United States
GR  - K12 HS022990/HS/AHRQ HHS/United States
GR  - K01 DK087894/DK/NIDDK NIH HHS/United States
PT  - Journal Article
DEP - 20160304
PL  - England
TA  - J Clin Pharm Ther
JT  - Journal of clinical pharmacy and therapeutics
JID - 8704308
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
SB  - IM
MH  - Adult
MH  - Blood Glucose/drug effects
MH  - Cross-Sectional Studies
MH  - Diabetes Mellitus, Type 2/*drug therapy
MH  - Female
MH  - Glycated Hemoglobin/metabolism
MH  - Health Behavior
MH  - Humans
MH  - Hypoglycemic Agents/*administration & dosage/therapeutic use
MH  - Male
MH  - *Medication Adherence
MH  - Middle Aged
MH  - Poverty
MH  - Self Care/*methods
MH  - Socioeconomic Factors
PMC - PMC4871756
MID - NIHMS766643
OTO - NOTNLM
OT  - glycaemic control
OT  - low income
OT  - medication adherence
OT  - type 2 diabetes
EDAT- 2016/03/05 06:00
MHDA- 2017/04/11 06:00
PMCR- 2016/06/01
CRDT- 2016/03/05 06:00
PHST- 2016/01/07 00:00 [received]
PHST- 2016/01/08 00:00 [accepted]
PHST- 2016/03/05 06:00 [entrez]
PHST- 2016/03/05 06:00 [pubmed]
PHST- 2017/04/11 06:00 [medline]
PHST- 2016/06/01 00:00 [pmc-release]
AID - 10.1111/jcpt.12360 [doi]
PST - ppublish
SO  - J Clin Pharm Ther. 2016 Jun;41(3):256-9. doi: 10.1111/jcpt.12360. Epub 2016 Mar 
      4.